Results of a multicenter randomized study to evaluate the safety and efficacy of combined immunotherapy with interleukin-2, interferon-a2b and histamine dihydrochloride versus dacarbazine in patients with stage IV melanomaMIDDLETON, M; HAUSCHILD, A; THOMSON, D et al.Annals of oncology. 2007, Vol 18, Num 10, pp 1691-1697, issn 0923-7534, 7 p.Article

A randomized phase II study of two schedules of bryostatin-1 (NSC339555) in patients with advanced malignant melanoma: A National Cancer Institute of Canada Clinical Trials Group StudyTOZER, R. G; BURDETTE-RADOUX, S; BERLANGER, K et al.Investigational new drugs. 2002, Vol 20, Num 4, pp 407-412, issn 0167-6997, 6 p.Article

An open randomised trial of second-line endocrine therapy in advanced breast cancer: comparison of the aromatase inhibitors letrozole and anastrozoleROSE, C; VTORAYA, O; BEN AYED, F et al.European journal of cancer (1990). 2003, Vol 39, Num 16, pp 2318-2327, issn 0959-8049, 10 p.Article

Epoetin alfa therapy increases hemoglobin levels and improves quality of life in patients with cancer-related anemia who are not receiving chemotherapy and patients with anemia who are receiving chemotherapyQUIRT, I; ROBESON, C; LAU, C. Y et al.Journal of clinical oncology. 2001, Vol 19, Num 21, pp 4126-4134, issn 0732-183XArticle

Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanomaRUSTHOVEN, J. J; QUIRT, I. C; VERMA, S et al.Journal of clinical oncology. 1996, Vol 14, Num 7, pp 2083-2090, issn 0732-183XArticle